maridebart cafraglutide vs tirzepatide Full article: for overweight and obesity management Once-Monthly Maridebart Cafraglutide for the

WVU Medicine J.W

Standard clinical dose escalation The FDA-approved Mounjaro (brand tirzepatide) follows this schedule: Weeks 1-4: 2.5 mg once weekly (starting dose, allows GI adaptation) Weeks 5-8: 5 mg once weekly (first therapeutic dose increase) Weeks 9-12: 7.5 mg once weekly (if tolerated and additional effect needed) Weeks 13-16: 10 mg once weekly (continued escalation) Weeks 17-20: 12.5 mg once weekly (approaching maximum) Week 21+: 15 mg once weekly (maximum approved dose) Each dose is maintained for at least four weeks before escalation

However, the drug is also linked to severe side effects, leading to numerous Ozempic lawsuits

Both are disqualifying

Patients with hyperbilirubinemia presented significantly lower erythrocyte counts and significantly higher reticulocyte counts compared to patients with low bilirubin levels [285]

They are not eligible for a Mounjaro prescription or prefer not to be written an off-label prescription